Clinical insights into diabetic gastroparesis: gastric scintigraphy-based diagnosis and treatment outcomes

Further Publications

Predictors of Outcomes After Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Systematic Review

Am J Gastroenterol

Varghese C, Lim A, Daker C, Sebaratnam G, Gharibans AA, Andrews CN, Hasler WL, O'Grady G, BSM Consortium and GPOEM-GEMS Study Group*

doi: 10.14309/ajg.0000000000003213

Inflammatory Bowel Disease

Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study

J Crohns Colitis

Zhao M, Larsen L, Dige A, Poulsen A, Lo B, Attauabi M, Dige Ovesen P, Wewer MD, Christiansen D, Hvas CL, Petersen AM, Bendtsen F, Seidelin J, Burisch J

doi: 10.1093/ecco-jcc/jjae192

Inflammatory Bowel Disease

Impact of Type 2 Diabetes on Clinical Outcomes and Advanced Therapy Use in Patients with Crohn's Disease: a Real-World Propensity Score-Matched Analysis

J Crohns Colitis

Massironi S, Solitano V, Furfaro F, D'Amico F, Zilli A, Allocca M, Peyrin-Biroulet L, Jairath V, Danese S

doi: 10.1093/ecco-jcc/jjaf157

Gastrointestinal Cancer

Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencing

Surgery

Baril JA, Ruedinger BM, Nguyen TK, Bilimoria KY, Ceppa EP, Maatman TK, Roch AM, Schmidt CM, Turk A, Yang AD, House MG, Ellis RJ

doi: 10.1016/j.surg.2024.07.055

Esophagus Diseases

Gastric (Foveolar) Dysplasia in Barrett's Esophagus: A Clinical, Molecular and Long-Term Outcome Study

Am J Gastroenterol

Wang HH, Ono Y, Paulson TG, Grady WM, Odze RD

doi: 10.14309/ajg.0000000000003450

Further Publications

AGA Clinical Practice Guideline on Management of Gastroparesis

Gastroenterology

Staller K, Parkman HP, Greer KB, Leiman DA, Zhou MJ, Singh S, Camilleri M, Altayar O, AGA Clinical Guidelines Committee

doi: 10.1053/j.gastro.2025.08.004

Further Publications

Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment

Clin Gastroenterol Hepatol

Panaccione R, Ferrante M, Dotan I, Panés J, Hisamatsu T, Bossuyt P, Danese S, Song A, Kalabic J, Joshi N, Zambrano J, Zhang Y, Duan WR, Kligys K, Dubinsky MC, Lindsay JO, Vermeire S, Siegmund B, Irving PM, D'Haens G

doi: 10.1016/j.cgh.2024.12.023

Gastrointestinal Cancer

Real-time use of computer-aided diagnosis in the optical diagnosis of gastric neoplasia: A multicenter randomized controlled trial

Clin Gastroenterol Hepatol

Higuchi K, Kaise M, Fujimoto A, Akimoto T, Ikeya T, Fukuzawa M, Yokoi C, Iizuka T, Noda H, Ishizuka N, Kirita K, Goto O, Iwakiri K

doi: 10.1016/j.cgh.2025.07.043

Inflammatory Bowel Disease

Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data

BMC Gastroenterol

Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R

doi: 10.1186/s12876-025-04022-7

Related content

Predictors of Outcomes After Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Systematic Review

Clinical outcomes after first-line anti-TNF treatment of patients with inflammatory bowel disease - a prospective multicenter cohort study

Impact of Type 2 Diabetes on Clinical Outcomes and Advanced Therapy Use in Patients with Crohn's Disease: a Real-World Propensity Score-Matched Analysis

Staging accuracy in patients with clinical T2N0 gastric cancer: Implications for treatment sequencing

Gastric (Foveolar) Dysplasia in Barrett's Esophagus: A Clinical, Molecular and Long-Term Outcome Study

AGA Clinical Practice Guideline on Management of Gastroparesis

Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction Treatment

Real-time use of computer-aided diagnosis in the optical diagnosis of gastric neoplasia: A multicenter randomized controlled trial

Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data